A detailed history of Louisiana State Employees Retirement System transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Louisiana State Employees Retirement System holds 12,500 shares of KRYS stock, worth $2.27 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
12,500
Holding current value
$2.27 Million
% of portfolio
0.04%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 24, 2024

BUY
$153.12 - $183.64 $1.91 Million - $2.3 Million
12,500 New
12,500 $2.3 Million

Others Institutions Holding KRYS

About Krystal Biotech, Inc.


  • Ticker KRYS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,664,300
  • Market Cap $4.67B
  • Description
  • Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...
More about KRYS
Track This Portfolio

Track Louisiana State Employees Retirement System Portfolio

Follow Louisiana State Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Louisiana State Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Louisiana State Employees Retirement System with notifications on news.